Please assess the completion status of the following clinical trial:

Trial Title: Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* HIV infection~* Antiretroviral naive~* CD4 cell count over 100/mm3~* Plasma HIV RNA load over 5,000 copies/mL~* Signed written informed consent~Exclusion Criteria:~* Hepatitis B infection~* Pregnancy~* Alcool abuse~* Acute infection, past neurological or pancreatic disease, biological abnormalities~* Chemotherapy or immunotherapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).